Your browser doesn't support javascript.
loading
Specialist Advice Support for Management of Severe Hereditary Angioedema Attacks: A Multicenter Cluster-Randomized Controlled Trial.
Javaud, Nicolas; Fain, Olivier; Durand-Zaleski, Isabelle; Launay, David; Bouillet, Laurence; Gompel, Anne; Sobel, Alain; Woimant, Maguy; Rabetrano, Hasina; Petrovic, Tomislav; Lapostolle, Frederic; Boccon-Gibod, Isabelle; Reuter, Paul-Georges; Bertrand, Philippe; Mezaour, Malha; Coppere, Brigitte; Floccard, Bernard; Kanny, Gisele; Baker, Elinor; Martin, Ludovic; Vicaut, Eric; Adnet, Frederic.
  • Javaud N; AP-HP, Urgences-Samu 93, hôpital Avicenne, Université Paris 13, Inserm U942, Bobigny, France; AP-HP, Urgences, Centre de référence sur les angiœdèmes à kinines, hôpital Louis Mourier, Université Paris 7, Colombes, France. Electronic address: nicolas.javaud@aphp.fr.
  • Fain O; Assistance Publique - Hôpitaux de Paris (AP-HP), Médecine Interne, DHUi2B, Centre de Référence associé sur les angiœdèmes à kinines, Hôpital Saint-Antoine, Université Paris 6, Paris, France.
  • Durand-Zaleski I; AP-HP, URCEco Ile de France, Hôpital de l'Hôtel-Dieu, Université Paris 12, Paris, France.
  • Launay D; Médecine Interne, Centre de Référence sur les angiœdèmes à kinines, Université de Lille, CHRU de Lille, Lille Cedex, France.
  • Bouillet L; Médecine Interne, Centre de Référence sur les angiœdèmes à kinines, CHU de Grenoble, Grenoble, France.
  • Gompel A; Université de Paris-Descartes, AP-HP, HUPC, Unité de Gynécologie Endocrinienne, Hôpital Port Royal, Paris, France.
  • Sobel A; AP-HP, Hôpital Hôtel Dieu, Université Paris 5, Paris, France.
  • Woimant M; AP-HP, Urgences-Samu 93, hôpital Avicenne, Université Paris 13, Inserm U942, Bobigny, France.
  • Rabetrano H; AP-HP, URCEco Ile de France, Hôpital de l'Hôtel-Dieu, Université Paris 12, Paris, France.
  • Petrovic T; AP-HP, Urgences-Samu 93, hôpital Avicenne, Université Paris 13, Inserm U942, Bobigny, France.
  • Lapostolle F; AP-HP, Urgences-Samu 93, hôpital Avicenne, Université Paris 13, Inserm U942, Bobigny, France.
  • Boccon-Gibod I; Médecine Interne, Centre de Référence sur les angiœdèmes à kinines, CHU de Grenoble, Grenoble, France.
  • Reuter PG; AP-HP, Urgences-Samu 93, hôpital Avicenne, Université Paris 13, Inserm U942, Bobigny, France.
  • Bertrand P; AP-HP, Urgences-Samu 93, hôpital Avicenne, Université Paris 13, Inserm U942, Bobigny, France.
  • Mezaour M; AP-HP, Urgences-Samu 93, hôpital Avicenne, Université Paris 13, Inserm U942, Bobigny, France.
  • Coppere B; Hospices Civils de Lyon, Médecine Interne, Lyon Cedex, France; Centre de Référence sur les angiœdèmes à kinines, CHU Edouard Herriot, Lyon Cedex, France.
  • Floccard B; Réanimation, CHU Edouard Herriot, Lyon Cedex, France.
  • Kanny G; Médecine Interne, Centre de Référence sur les angiœdèmes à kinines, CHU de Nancy, Nancy, France.
  • Baker E; AP-HP, Urgences-Samu 93, hôpital Avicenne, Université Paris 13, Inserm U942, Bobigny, France.
  • Martin L; Dermatologie, Centre de Référence sur les angiœdèmes à kinines, Université d'Angers, CHU d'Angers, Angers cedex, France.
  • Vicaut E; AP-HP, Unité de Recherche Clinique, hôpital Fernand Widal, Paris, France.
  • Adnet F; AP-HP, Urgences-Samu 93, hôpital Avicenne, Université Paris 13, Inserm U942, Bobigny, France; Inserm U942.
Ann Emerg Med ; 72(2): 194-203.e1, 2018 08.
Article en En | MEDLINE | ID: mdl-29503044
ABSTRACT
STUDY

OBJECTIVE:

Hereditary angioedema is a rare disease associated with unpredictable, recurrent attacks of potentially life-threatening edema. Management of severe attacks is currently suboptimal because emergency medical teams are often unaware of new specific treatments. The objective of this trial is to test whether a dedicated national telephone care-management strategy would reduce resource use during severe hereditary angioedema attacks.

METHODS:

We conducted a cluster-randomized multicenter prospective trial of patients with a documented diagnosis of hereditary angioedema (type I, II or FXII hereditary angioedema). Participants were enrolled between March 2013 and June 2014 at 8 participating reference centers. The randomized units were the reference centers (clusters). Patients in the intervention arm were given a national free telephone number to call in the event of a severe attack. Emergency physicians in the SOS-hereditary angiœdema (SOS-HAE) call center were trained to advise or prescribe specific treatments. The primary outcome was number of admissions for angioedema attacks. Economic evaluation was also performed.

RESULTS:

We included 100 patients in the SOS-HAE group and 100 in the control group. During the 2 years, there were 2,368 hereditary angioedema attacks among 169 patients (85%). Mean number of hospital admissions per patient in the 2-year period was significantly greater in the usual-practice group (mean 0.16 [range 0 to 2] versus 0.03 [range 0 to 1]); patient risk difference was significant -0.13 (95% confidence interval -0.22 to -0.04; P=.02). Probabilistic sensitivity graphic analysis indicated a trend toward increased quality-adjusted life-years in the SOS-HAE group.

CONCLUSION:

A national dedicated call center for management of severe hereditary angioedema attacks is associated with a decrease in hospital admissions and may be cost-effective if facilities and staff are available to deliver the intervention alongside existing services.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Admisión del Paciente / Angioedemas Hereditarios Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Admisión del Paciente / Angioedemas Hereditarios Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article